ICON released findings from 2 biotech surveys, including global trends update and Chinese market growth. Insights from 260+ professionals worldwide.
Dublin-based ICON plc, a top clinical research organization listed on NASDAQ with the ticker symbol ICLR, unveiled results from two recent biotech sector surveys. The initial survey delved into global biotech trends, building upon a 2023 survey, while the subsequent survey honed in on the flourishing Chinese biotech landscape. Together, over 260 biotech professionals and venture capital executives from the US, Europe, and Asia-Pacific shared their perspectives in these surveys.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments